Pulmonary & Respiratory Medicine

Division of Pulmonary, Critical Care and Sleep Medicine, Stony Brook University, New York, USA

Publications

• Perspective   
  A Perspective on the Majority of Current Coronavirus Medications is either orally or intravenously
  Author(s): Sunena Williams*
  
  A small amount of the drug is delivered to the lung because to poor absorption or gastrointestinal degradation in the vast majority of ongoing antiviral/hostile to SARS-CoV-2 specialists that are taken orally. In order to treat pneumonic diseases like the Coronavirus, breathed-in treatment by pneumonic medicine conveyance could be considered an expected strategy. It is possible to directly deliver pharmaceuticals to the lung using pneumonic conveyance, which ensures higher medication fixation in the lung and avoids unpleasant side effects because lesser dosages are needed... Read More»
  DOI: 10.37421/2161-105X.2022.12.616

  Abstract HTML PDF